Reference no: EM132122540

Consumer/customer analysis according to this Company Description

[Company name] was started by cofounders ( names ) to innovate in medical technologies dedicated to cure cancer. [Company name] is known best for its greatest innovation and state-of-the-art product [product name], a smart set of independent nanobots injected into the human’s body to prevent, protect and cure from malignant growth and tumor. The [main product name] was first launched with the help of RAK Incubator and Accelerator located in Ras Al-Khaimah, United Arab Emirates. It resumed its development and growth in [top medical research institute]. For two years, [company name] has been expanding and establishing its products in hospitals and medical institutes.

The company’s success in combining artificial intelligence with nanobots has sparkled an upsurge in medical research and development. Cancer prevention and protection have observed a high increase and success by [product name], nanobots that monitor and remain in the human body for long periods of time. In addition, more than 13,000 patients diagnosed with [type of cancer] has been successfully treated and cured with [product name]. This positive feedback has pushed [dummy company name_1] and [dummy company name_2] to start and develop …

[Company name] believes that its able to expand [product name] to treat more complex types of cancer and diseases. This marketing plan outlines how the company will extend its products capabilities. In addition, new strategies will be introduced to spread its adaption by medical institutes from 93 to 200 institutes by the year 2023.